> Genentech is offering $2 billion in senior notes to upgrade facilities, fund R&D and for other purposes. Story
> Hi-Tech Pharmacal of Amityville, New York, has acquired the US rights to the brands Zostrix and Zostrix HP, topical analgesic creams from Rodlen Laboratories. Release
> Seattle-based Corixa announced that its shareholders have approved a takeover by GlaxoSmithKline. Story
> Vitae Pharmaceuticals has secured $15 million in financing. Release
And Finally... In the first survey of its kind, researchers found that at least 12,000 Pennsylvanians contracted a hospital infection, costing an extra $2 billion in care and leading to 1,500 preventable deaths. Article